MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Histological discrimination of malignancy in mucinous ovarian tumours.
Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
Monoclonal antibodies against CA125-bearing antigenic molecule fragments; reactivity with mucinous ovarian tumours and lung cancers.
Ovarian tumours in pregnancy.
Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.
Differentiating primary and extragenital metastatic mucinous ovarian tumours: an algorithm combining PAX8 with tumour size and laterality.
Histochemical demonstration of gastrointestinal mucins in ovarian mucinous cystadenoma.
Fertility sparing treatment in borderline ovarian tumours.
cyclophosphamide chemotherapy.
[Lymphography in malignant ovarian tumours (author's transl)].
Aberrant subcellular immunolocalization of NOTCH-1 activated intracellular domain in feline mammary tumours.
Mucinous Borderline Ovarian Tumor in Very Old Aged Postmenopausal Woman.
C-myc oncogene product p62 in ovarian mucinous neoplasms.
Thromboplastic activity of human ovarian tumours.
Immunocytochemical staining of ovarian tumours with Ov632.
Right Ovarian Mucinous Cystadenoma Coexisting with an Incidental Left Ovarian Haemangioma in a Postmenopausal Patient.
Port-site metastasis of mucinous borderline ovarian tumor after laparoscopy.
MRI appearances of mucinous borderline ovarian tumors: pathological correlation.
Isolation of bovine ovarian inhibin, its immunoneutralization in vitro and immunolocalization in bovine ovary.
Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study.
Ovarian mucinous tumor with malignant mural nodules: dedifferentiation or collision?
Genome-wide significant risk associations for mucinous ovarian carcinoma.
Zollinger-Ellison syndrome associated with ovarian mucinous cystadenocarcinoma.
Ultrasound in the diagnosis and treatment of ovarian cystic tumours.
Immunolocalization of alpha-amylase in ovarian mucinous tumours.
The distribution of alpha-amylase was studied immunohistochemically in 42 cases of ovarian mucinous tumour. Intense immunoreactivity for amylase was f...
344KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Histological discrimination of malignancy in mucinous ovarian tumours.
Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
Monoclonal antibodies against CA125-bearing antigenic molecule fragments; reactivity with mucinous ovarian tumours and lung cancers.
Ovarian tumours in pregnancy.
Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.
Differentiating primary and extragenital metastatic mucinous ovarian tumours: an algorithm combining PAX8 with tumour size and laterality.
Histochemical demonstration of gastrointestinal mucins in ovarian mucinous cystadenoma.
Fertility sparing treatment in borderline ovarian tumours.
cyclophosphamide chemotherapy.
[Lymphography in malignant ovarian tumours (author's transl)].
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms